COMBINATION THERAPIES WITH LFMAU FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION

Details for Australian Patent Application No. 2003253888 (hide)

Owner TRIANGLE PHARMACEUTICALS, INC.

Inventors FURMAN, Phillip, A.

Pub. Number AU-A-2003253888

PCT Number PCT/US03/21811

PCT Pub. Number WO2004/006843

Priority 60/396,117 15.07.02 US

Filing date 11 July 2003

Wipo publication date 2 February 2004

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 60/396,117 15.07.02 US

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003253888

28 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003253889-Determining taxes by applying tax rules specified using configurable templates.

2003253887-NOVEL SALT FORMS OF POORLY SOLUBLE PROBUCOL ESTERS AND ETHERS